ethyl 6-nitro-1-naphthoate | 91901-44-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: ethyl 6-nitro-1-naphthoate
• 英文别名: 6-nitro-[1]naphthoic acid ethyl ester；6-Nitro-[1]naphthoesaeure-aethylester；ethyl 6-nitronaphthalene-1-carboxylate
• CAS: 91901-44-9
• 化学式: C₁₃H₁₁NO₄
• 分子量: 245.235
• InChiKey: DTITWIADHXIFEI-UHFFFAOYSA-N

物化性质

• 沸点：
  399.4±15.0 °C(Predicted)
• 密度：
  1.292±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  72.1
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  ethyl 6-nitro-1-naphthoate 生成 6-Diazonio-naphthoesaeure-(1)-ethylester
  参考文献：
  名称：

  Substituent Effects. VIII.¹ Synthesis of Substituted α- and β-Fluoronaphthalenes²

  摘要：

  DOI：

  10.1021/ja00978a038
• 作为产物：
  描述：

  乙醇 、 3-硝基-1,8-萘二甲酸酐 在 sodium hydroxide 、 硫酸 、 mercury(II) oxide 作用下， 生成 3-硝基-1-萘甲酸 、 ethyl 6-nitro-1-naphthoate
  参考文献：
  名称：

  Synthesis and structure-activity study of protease inhibitors. II. Amino- and guanidino-substituted naphthoates and tetrahydronaphthoates.

  摘要：

  合成了多种氨基和氨基脲取代的萘酸酯和四氢萘酸酯，并评估了它们对胰蛋白酶、纤溶酶、激肽酶、凝血酶和C1酯酶的抑制活性。在这些化合物中，苯基4-氨基脲-1-萘酸酯（IIIj）和苯基6-氨基脲-1-萘酸酯（IIIl）表现出强效选择性的胰蛋白酶抑制（IC50：4×10^-7和5×10^-8 M，分别），而苯基7-氨基脲-1, 2, 3, 4-四氢-1-萘酸酯（Vb）和对乙氧基羧基苯基7-氨基脲-1, 2, 3, 4-四氢-1-萘酸酯（Vg）则对凝血酶具有选择性抑制活性（IC50：4×10^-5和1×10^-5 M，分别）。

  DOI：

  10.1248/cpb.32.3968

文献信息

• Benzoxazepinones and their use as squalene synthase inhibitors
  申请人：——

  公开号：US20030078251A1

  公开（公告）日：2003-04-24

  There is disclosed a compound represented by the formula [I]: 1 wherein R 1 is optionally substituted 1-carboxyethyl group, optionally substituted alkyl-sulfonyl group, optionally substituted (carboxy-cycloalkyl)-alkyl group, —X 1 —X 2 —Ar—X 3 —X 4 —COOH (wherein X 1 and X 4 are a bond or alkylene group, X 2 and X 3 are a bond, —O—, —S—, Ar is divalent aromatic group etc.), R 2 is alkyl group optionally substituted with alkanoyloxy group and/or hydroxy group, R 3 is alkyl group, and W is halogen atom, etc., or a salt thereof. The compound has the cholesterol lowering activity and the triglyceride lowering activity and is useful for preventing and/or treating hyperlipidemia.

  披露了一种由公式[I]表示的化合物： 1 其中R 1 是可选地取代的1-羧乙基，可选地取代的烷基亚磺酰基，可选地取代的(羧基环烷基)-烷基，—X 1 —X 2 —Ar—X 3 —X 4 —COOH(其中X 1 和X 4 是键或亚烷基，X 2 和X 3 是键，—O—，—S—，Ar是二价芳香族等)，R 2 是可选地由酰氧基和/或羟基取代的烷基，R 3 是烷基，W是卤素原子等，或其盐。该化合物具有降低胆固醇活性和降低甘油三酯活性，用于预防或治疗高脂血症。
• BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1292585A1

  公开（公告）日：2003-03-19
• [EN] BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS<br/>[FR] BENZOXAZEPINONES ET LEUR UTILISATION COMME INHIBITEURS DE LA SQUALENE SYNTHASE
  申请人：TAKEDA CHEMICAL INDUSTRIES LTD

  公开号：WO2001098282A1

  公开（公告）日：2001-12-27

  There is disclosed a compound represented by formula (I), wherein R1 is optionally substituted 1-carboxyethyl group, optionally substituted alkyl-sulfonyl group, optionally substituted (carboxy-cycloalkyl)-alkyl group, -X?1-X2-Ar-X3-X4¿-COOH (wherein X?1 and X4¿ are a bond or alkylene group, X?2 and X3¿ are a bond, -O-, -S-, Ar is divalent aromatic group , etc.), R2 is alkyl group optionally substituted with alkanoyloxy group and/or hydroxy group, R3 is alkyl group, and W is halogen atom, etc., or a salt thereof. The compound has the cholesterol lowering activity and the triglyceride lowering activity and is useful for preventing and/or treating hyperlipidemia.
• Substituent Effects. VIII.¹ Synthesis of Substituted α- and β-Fluoronaphthalenes²
  作者：W. Adcock、M. J. S. Dewar

  DOI：10.1021/ja00978a038

  日期：1967.1
• Synthesis and structure-activity study of protease inhibitors. II. Amino- and guanidino-substituted naphthoates and tetrahydronaphthoates.
  作者：TOYOO NAKAYAMA、TOSHIYUKI OKUTOME、RYOJI MATSUI、MASATERU KURUMI、YOJIRO SAKURAI、TAKUO AOYAMA、SETSURO FUJII

  DOI：10.1248/cpb.32.3968

  日期：——

  Various amino-and guanidino-substituted naphthoates and tetrahydronaphthoates were synthesized and evaluated for inhibitory activities against trypsin, plasmin, kallikrein, thrombin and Cl esterase. Among these compounds, phenyl 4-guanidino-1-naphthoate (IIIj) and phenyl 6-guanidino-1-naphthoate (IIIl) exhibited potent and selective trypsin inhibition (IC50 : 4×10-7 and 5×10-8 M, respectively) and phenyl 7-guanidino-1, 2, 3, 4-tetrahydro-1-naphthoate (Vb) and p-ethoxycarbonylphenyl 7-guanidino-1, 2, 3, 4-tetrahydro-1-naphthoate (Vg) had selective inhibitory activities against thrombin (IC50 : 4×10-5 and 1×10-5 M, respectively).

  合成了多种氨基和氨基脲取代的萘酸酯和四氢萘酸酯，并评估了它们对胰蛋白酶、纤溶酶、激肽酶、凝血酶和C1酯酶的抑制活性。在这些化合物中，苯基4-氨基脲-1-萘酸酯（IIIj）和苯基6-氨基脲-1-萘酸酯（IIIl）表现出强效选择性的胰蛋白酶抑制（IC50：4×10^-7和5×10^-8 M，分别），而苯基7-氨基脲-1, 2, 3, 4-四氢-1-萘酸酯（Vb）和对乙氧基羧基苯基7-氨基脲-1, 2, 3, 4-四氢-1-萘酸酯（Vg）则对凝血酶具有选择性抑制活性（IC50：4×10^-5和1×10^-5 M，分别）。